This HTML5 document contains 42 embedded RDF statements represented using HTML+Microdata notation.

The embedded RDF content will be recognized by any processor of HTML5 Microdata.

Namespace Prefixes

PrefixIRI
wdthttp://www.wikidata.org/prop/direct/
n8http://dx.doi.org/10.5414/
wdtnhttp://www.wikidata.org/prop/direct-normalized/
schemahttp://schema.org/
rdfshttp://www.w3.org/2000/01/rdf-schema#
skoshttp://www.w3.org/2004/02/skos/core#
wikibasehttp://wikiba.se/ontology#
phttp://www.wikidata.org/prop/
rdfhttp://www.w3.org/1999/02/22-rdf-syntax-ns#
n10http://rdf.ncbi.nlm.nih.gov/pubchem/reference/
xsdhhttp://www.w3.org/2001/XMLSchema#
wdshttp://www.wikidata.org/entity/statement/
wdhttp://www.wikidata.org/entity/

Statements

Subject Item
wd:Q95432218
rdf:type
wikibase:Item
schema:description
wetenschappelijk artikel article scientifique publié en 2018 наукова стаття
p:P577
wds:Q95432218-A6F1C2CC-1979-48FD-A86E-ADE37A9A33B8
wdt:P577
2018-02-01T00:00:00Z
p:P2093
wds:Q95432218-A5912FF0-D4FB-48DF-A0CA-B21E0AE42088 wds:Q95432218-8EFCA439-2FB0-403D-8FC2-F33E777D8C6B wds:Q95432218-22F69A1F-A96C-4B19-9BE9-27BFAF87E294 wds:Q95432218-31768216-79A9-4ED6-9233-708D5A4C2FBA wds:Q95432218-E8D155A7-19A7-4631-876F-D894CEEC95AE
wdt:P2093
Kylie Reed Karolina Bogdanowicz James Bell Alastair Knight Shelagh Baillie
rdfs:label
Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
skos:prefLabel
Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
schema:name
Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
p:P50
wds:Q95432218-EF35472D-51FB-4745-B76E-BD73819956C7
wdt:P50
wd:Q47270318
p:P1476
wds:Q95432218-66FA4B50-89E7-4F1F-BAF3-8A18D7D2546B
wdt:P1476
Norbuprenorphine and respiratory depression: Exploratory analyses with new lyophilized buprenorphine and sublingual buprenorphine
p:P304
wds:Q95432218-C65D0261-D550-48BA-BAE0-E1E89555F540
wdt:P304
81-85
p:P31
wds:Q95432218-BA584170-C9B8-4998-8D75-F208A136FD54
wdt:P31
wd:Q13442814
p:P698
wds:Q95432218-AB001B22-4BB6-4C1F-88FC-2C32F907B9EF
wdtn:P698
n10:29231163
wdt:P698
29231163
p:P1433
wds:Q95432218-E9355B08-9801-482D-B81F-FE94318562DF
wdt:P1433
wd:Q15751305
p:P433
wds:Q95432218-0FCF2163-4620-4258-8C0D-C98967E744D0
p:P478
wds:Q95432218-C217376C-0E08-429A-BC47-58468421934F
wdt:P433
2
wdt:P478
56
p:P356
wds:Q95432218-00C14A1E-5376-47E4-899F-5AF3C7E3FA33
wdtn:P356
n8:CP203118
wdt:P356
10.5414/CP203118